AJP - Heart AJP: Endocrinology and Metabolism
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH
 QUICK SEARCH:   [advanced]


     


Am J Physiol Heart Circ Physiol (September 23, 2004). doi:10.1152/ajpheart.00617.2004
This Article
Right arrow Full Text (PDF)
Right arrow All Versions of this Article:
288/2/H591    most recent
00617.2004v1
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Kahn, M.
Right arrow Articles by Tulenko, T. N.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Kahn, M.
Right arrow Articles by Tulenko, T. N.
Submitted on June 21, 2004
Accepted on September 5, 2004

Influence of Serum Cholesterol on Atherogenesis and Intimal Hyperplasia After Angioplasty: Inhibition by Amlodipine

Mark Kahn1, Kathleen Boesze-Battagllia2, David W. Stepp3, Artium Petrov4, Yong Huang5, R. Preston Mason6, and Thomas N. Tulenko5*

1 surgery, Albert Einstein Medical Center, Philadelphia, PA, USA
2 Biochemistry, University of Pennsylvania Dental School, Philadelphia, PA, USA
3 Vascular Biology Center, Medical College of Georgia, Augusta, GA, USA
4 Medicine, University of California Medical Center, Orange, CA, USA
5 Surgery, Thomas Jefferson University, Philadelphia, PA, USA
6 --, Elucida Research, Beverly, MA, USA

* To whom correspondence should be addressed. E-mail: Thomas.Tulenko{at}jefferson.edu.

Object: to determine whether serum hypercholesterolemia (HC) promotes the development of spontaneous and angioplasty-induced lesions, and whether amlodipine inhibits these lesions and cellular processes underlying their genesis. Rabbits were fed normal (N), 0.5% or 2% cholesterol diets for 9 weeks which resulted in the development of increasing HC. After week one, balloon dilation of the abdominal aorta was performed, while the thoracic aorta was not disturbed and monitored for the development of spontaneous lesions. Lesion size increased with the degree of HC and was accompanied by an increased collagen synthesis and SMC proliferation at each site. Amlodipine (5 mg/kg, p.o.) inhibited lesion size 50% (p<.01) at both sites in cholesterol-fed animals, but not at angioplasty sites in animals on normal diet. Local collagen synthesis was inhibited at both sites by amlodipine in the diet animals. The increase in HC was accompanied by a 1.7-fold increase in basal Ca++ uptake in SMC in the thoracic aorta which was not altered by amlodipine, nifedipine, Ni++ or La+++ revealing an uninhibitable calcium leak during atherogenesis. In culture, cholesterol enrichment increased SMC proliferation, collagen synthesis and the secretion of a soluble SMC mitogen, which were inhibited by amlodipine (10-9 M). Lastly, in SMC membranes, amlodipine uniquely restored the cholesterol-expanded membrane bilayer width without any effect on membrane fluidity. This study establishes a causal role between serum HC and the development of spontaneous and angioplasty-induced lesions, and the ability of amlodipine to disrupt this action by a novel remodelling action on the SMC cell membrane.




This article has been cited by other articles:


Home page
Cardiovasc ResHome page
S. Batova, J. DeWever, T. Godfraind, J.-L. Balligand, C. Dessy, and O. Feron
The calcium channel blocker amlodipine promotes the unclamping of eNOS from caveolin in endothelial cells
Cardiovasc Res, August 1, 2006; 71(3): 478 - 485.
[Abstract] [Full Text] [PDF]


Home page
J. Lipid Res.Home page
V. da Cunha, B. Martin-McNulty, J. Vincelette, L. Zhang, J. C. Rutledge, D. W. Wilson, R. Vergona, M. E. Sullivan, and Y.-X. Wang
Interaction between mild hypercholesterolemia, HDL-cholesterol levels, and angiotensin II in intimal hyperplasia in mice
J. Lipid Res., March 1, 2006; 47(3): 476 - 483.
[Abstract] [Full Text] [PDF]


Home page
J. Lipid Res.Home page
T. N. Tulenko, K. Boeze-Battaglia, R. P. Mason, G. S. Tint, R. D. Steiner, W. E. Connor, and E. F. Labelle
A membrane defect in the pathogenesis of the Smith-Lemli-Opitz syndrome
J. Lipid Res., January 1, 2006; 47(1): 134 - 143.
[Abstract] [Full Text] [PDF]




HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH
Visit Other APS Journals Online
Copyright © 1977 by the American Physiological Society.